 Lack effect peroral acyclovir treatment acute infectious mononucleosis acyclovir therapy acute infectious mononucleosis multicentered double-blind placebo-controlled trial total patients mg acyclovir placebo times days patients study days symptom onset positive Monospot test Analysis mean values time resolution fever lymphadenopathy weight change hepatomegaly splenomegaly liver function tests atypical lymphocytes hours bed rest sense well-being normal activities significant differences trend suppression Epstein-Barr virus excretion oropharynx acyclovir recipients toxicity patients acyclovir conditions study evidence treatment course infectious mononucleosis